Serenno Prepares US Launch Of Kidney Damage Detection Device
Israeli start-up Serenno Medical is targeting 2020 for US FDA clearance and launch of its Sentinel device for early detection and prevention of acute kidney injury, a condition that affects 19 million patients worldwide every year.
You may also be interested in...
Barcode Diagnostics is developing a nanotechnology for personalized cancer drug screening. The start-up’s aim is to provide physicians with a tool that matches patients with the most effective medicine, during the different stages of disease.
Dutch data-capture company Castor is aiming to make the world’s medical research data reusable. The cloud-based platform enables medical device companies to capture, process and integrate data from multiple sources on a centralized platform.
Ophthalmic start-up CorNeat Vision is entering a multi-center clinical trial for its artificial cornea device CorNeat KPro. The implant uses advanced cell technology to biomimic the cellular structure of the eye and integrate with tissue. Medtech Insight met with CorNeat's CEO, Almog Aley-raz and CMO, Gilad Litvin at the OurCrowd Global Investor in Jerusalem, February 13, to hear more.